Quadrant Capital Group’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,859
| Closed | -$38.6K | – | 2363 |
|
|
2025
Q1 | $38.6K | Buy |
4,859
+2,840
| +141% | +$22.6K | ﹤0.01% | 1803 |
|
|
2024
Q4 | $11K | Buy |
2,019
+899
| +80% | +$4.88K | ﹤0.01% | 2096 |
|
|
2024
Q3 | $8.09K | Buy |
1,120
+784
| +233% | +$5.66K | ﹤0.01% | 2203 |
|
|
2024
Q2 | $3.65K | Buy |
+336
| New | +$3.65K | ﹤0.01% | 2371 |
|
|
2023
Q4 | – | Sell |
-689
| Closed | -$14.2K | – | 2769 |
|
|
2023
Q3 | $14.2K | Buy |
689
+647
| +1,540% | +$13.3K | ﹤0.01% | 1852 |
|
|
2023
Q2 | $1.98K | Sell |
42
-20
| -32% | -$940 | ﹤0.01% | 2420 |
|
|
2023
Q1 | $2.6K | Buy |
62
+20
| +48% | +$839 | ﹤0.01% | 2379 |
|
|
2022
Q4 | $1.6K | Sell |
42
-25
| -37% | -$954 | ﹤0.01% | 2469 |
|
|
2022
Q3 | $3K | Hold |
67
| – | – | ﹤0.01% | 2296 |
|
|
2022
Q2 | $2K | Buy |
67
+42
| +168% | +$1.25K | ﹤0.01% | 2271 |
|
|
2022
Q1 | $1K | Sell |
25
-34
| -58% | -$1.36K | ﹤0.01% | 2377 |
|
|
2021
Q4 | $3K | Buy |
59
+31
| +111% | +$1.58K | ﹤0.01% | 2059 |
|
|
2021
Q3 | $1K | Sell |
28
-32
| -53% | -$1.14K | ﹤0.01% | 2380 |
|
|
2021
Q2 | $3K | Sell |
60
-9
| -13% | -$450 | ﹤0.01% | 2032 |
|
|
2021
Q1 | $5K | Sell |
69
-12
| -15% | -$870 | ﹤0.01% | 1802 |
|
|
2020
Q4 | $7K | Buy |
81
+15
| +23% | +$1.3K | ﹤0.01% | 1589 |
|
|
2020
Q3 | $4K | Buy |
66
+41
| +164% | +$2.49K | ﹤0.01% | 1652 |
|
|
2020
Q2 | $1K | Sell |
25
-85
| -77% | -$3.4K | ﹤0.01% | 2118 |
|
|
2020
Q1 | $3K | Buy |
110
+103
| +1,471% | +$2.81K | ﹤0.01% | 1808 |
|
|
2019
Q4 | $0 | Sell |
7
-169
| -96% | – | ﹤0.01% | 2479 |
|
|
2019
Q3 | $23K | Sell |
176
-172
| -49% | -$22.5K | ﹤0.01% | 1554 |
|
|
2019
Q2 | $62K | Hold |
348
| – | – | 0.01% | 1115 |
|
|
2019
Q1 | $53K | Buy |
348
+341
| +4,871% | +$51.9K | 0.01% | 1191 |
|
|
2018
Q4 | $0 | Buy |
+7
| New | – | ﹤0.01% | 2279 |
|